- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Licensing
Licensing activities are excellent opportunities for companies that want to expand their portfolio or gain return on investment in a relatively short period.
Out-licensing is a new phenomenon for the Indian pharma. The licensing strategy can make a critical drug globally accessible, and technology collaboration can enable an experimental drug for early entry. We also do product development and offer early entry to the Emerging & Expansion markets.
We cater to diverse portfolios across USA, EU, Japan & ANZ.
Your Benefit:
- Local expertise in most regulated and emerging markets.
- Insights into the needs of our customer and access to decision makers.
- Ability to handle the particularities with local know-how.
- Track record of successful license deals.
- Customized services - Regulatory Affairs, Intellectual Property, Quality & Supply Chain Management.